関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
miR156とmiR172の連続的な作用は,アラビドプシスの発達のタイミングを調節する
Gang Wu1, Mee Yeon Park, Susan R Conway
1Department of Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cell
|August 26, 2009
まとめ
植物発達の移行は,マイクロRNAによって調節されます. miR156は青年期を維持し,miR172は成人のアイデンティティを促進し,連続的なアクションとフィードバックループを通じてスイッチを調整します.
科学分野:
- 植物生物学 植物生物学
- 発達生物学 発達生物学とは
- 分子遺伝学 分子遺伝学
背景:
- 植物の発芽の発達には,幼生期から成人期への移行があり,形態学的変化と生殖能力の向上が特徴です.
- この重要な発達スイッチを制御する分子メカニズムを理解することは,植物科学にとって不可欠です.
研究 の 目的:
- 植物の発芽の発達における若年期から成人期への移行を制御する規制ネットワークを解明する.
- この移行のタイミングと調整に関与する重要なマイクロRNAと転写因子を特定する.
主な方法:
- マイクロRNA (miRNA) と転写因子 (SPL) の発現パターンの分析.
- 遺伝子操作を用いた機能的研究で,キーレギュレータの必要性と十分性を評価する.
- miR156,miR172およびSPL遺伝子間の規制関係を調査する.
主要な成果:
- マイクロRNA156 (miR156) は,幼稚期を維持するために必要かつ十分である.
- miR156はSPL転写因子を抑制し,SPL転写因子は miR172.2を含む下流経路を調節する.
- miR172は,成人表皮の同一性を促進するためにmiR156の下流で作用し,SPL9とSPL10はmiR172bの転写を媒介する.
- miR156,miR172を含む負のフィードバックループとそのターゲットは,相安定に寄与する.
結論:
- 植物における青年期から成人期への移行は,miRNAs,miR156およびmiR172.2の連続的な作用によって調整されます.
- このmiRNA媒介の経路は,発芽発達の様々な側面を調整し,適時な移行を保証する.
- 発見は,発達タイミングの保存されたメカニズムを明らかにし,C. elegans.などの他の生物の移行に並行しています.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K